Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
The Zucker Hillside Hospital |
---|---|
Information provided by: | The Zucker Hillside Hospital |
ClinicalTrials.gov Identifier: | NCT00768677 |
This is a study of topiramate to see whether topiramate decreases binge eating behavior among adolescents and young adults. The investigators did also checked whether topiramate affected cognitive function or not.
Condition | Intervention |
---|---|
Eating Disorders Bulimia Nervosa |
Drug: topiramate |
Study Type: | Interventional |
Study Design: | Treatment, Single Group Assignment |
Official Title: | Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents |
Ages Eligible for Study: | 12 Years to 23 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Subjects (aged 12 to 23) were included if they
Exclusion Criteria:
Responsible Party: | The Zucker Hillside Hospital ( Ema Saito ) |
Study ID Numbers: | 03-04-063 |
Study First Received: | October 7, 2008 |
Last Updated: | October 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00768677 |
Health Authority: | United States: Institutional Review Board |
binge eating behavior adolescents |
Signs and Symptoms Bulimia Nervosa Signs and Symptoms, Digestive Mental Disorders |
Bulimia Topiramate Eating Disorders Hyperphagia |
Anti-Obesity Agents Pathologic Processes Disease Therapeutic Uses Physiological Effects of Drugs |
Protective Agents Neuroprotective Agents Central Nervous System Agents Pharmacologic Actions Anticonvulsants |